CALTON & ASSOCIATES, INC. - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 151 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
CALTON & ASSOCIATES, INC. ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$298,000
+25.7%
9,608
-1.7%
0.08%
+53.8%
Q3 2021$237,000
-6.0%
9,776
-3.2%
0.05%
+6.1%
Q1 2021$252,000
-8.4%
10,098
+0.1%
0.05%0.0%
Q4 2020$275,00010,0850.05%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,084,300$15,820,0003.32%
ARMISTICE CAPITAL, LLC 5,748,000$83,863,0001.50%
RA Capital Management 5,614,428$81,915,0001.32%
Krensavage Asset Management, LLC 140,000$2,043,0000.69%
CM Management, LLC 60,000$875,0000.63%
Altium Capital Management LP 170,484$2,487,0000.58%
HighVista Strategies LLC 53,498$781,0000.55%
Sio Capital Management, LLC 150,000$2,189,0000.54%
MANGROVE PARTNERS IM, LLC 295,037$4,305,0000.44%
Rock Springs Capital Management LP 1,494,164$21,800,0000.43%
View complete list of TRAVERE THERAPEUTICS INC shareholders